Quarterly report pursuant to Section 13 or 15(d)

STOCK OPTIONS

v3.23.3
STOCK OPTIONS
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK OPTIONS

11. STOCK OPTIONS

 

A summary of option activity for the nine months ended September 30, 2023 is presented below.

 

    Options     Weighted- Average Exercise Price     Weighted- Average Remaining Contractual Life (Years)     Aggregate Intrinsic Value  
                         
Outstanding at January 1, 2023     139,054     $ 52.11       3.37     $                   -  
Granted     2,028,425       0.95       -       -  
Forfeited     (110,597 )     60.48       -       -  
Exercised     -       -       -       -  
Outstanding at September 30, 2023     2,056,882     $ 1.21       4.85     $ -  
                                 
Vested September 30, 2023     319,434     $ 1.99             $ -  
                                 
Exercisable at September 30, 2023     319,434     $ 1.99             $ -  

 

At September 30, 2023, the intrinsic value of the outstanding options was $0.

 

During the nine months ended September 30, 2023, the Company granted stock options to board members to purchase a total of 8,090 stock options as replacement awards related to forfeited restricted stock units. The options have an average exercise price of $9.20 per share, expire in five years, and vested on the grant date. The total fair value of these options at grant date was $66 using the Black-Scholes Option Pricing model.

 

On June 21, 2023, the Company granted stock options to board members to purchase a total of 997,595 stock options. The options have an average exercise price of $1.11 per share, expire in five years, and vest annually over 4 years. The total grant date fair value of these options was $953 based on the Black-Scholes option pricing model.

 

On September 28, 2023, the Company granted stock options to employees and a board member to purchase a total of 1,022,740 stock options. The options have an average exercise price of $0.73 per share, expire in five years, and vest annually over 4 years. The total grant date fair value of these options was $676 based on the Black-Scholes option pricing model.

 

The share-based compensation expense recognized relating to the vesting of stock options for the three and nine months ended September 30, 2023 amounted to $440 and $954, respectively. As of September 30, 2023, the total unrecognized share-based compensation expense was $1,795, which is expected to be recognized as part of operating expense through September 2027.

 

The fair value of share option award is estimated using the Black-Scholes option pricing method based on the following weighted-average assumptions:

 

   

Nine Months Ended September 30,

 
    2023     2022  
Risk-free interest rate     4.29 %     1.24% - 3.37 %
Average expected term     5 years       5 years  
Expected volatility     136.2 %     143.6-149.5 %
Expected dividend yield     -       -  

 

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of measurement corresponding with the expected term of the share option award; the expected term represents the weighted-average period of time that share option awards granted are expected to be outstanding giving consideration to vesting schedules and historical participant exercise behavior; the expected volatility is based upon historical volatility of the Company’s common stock; and the expected dividend yield is based on the fact that the Company has not paid dividends in the past and does not expect to pay dividends in the future.